Literature DB >> 16024614

A mouse model of human breast cancer metastasis to human bone.

Charlotte Kuperwasser1, Scott Dessain, Benjamin E Bierbaum, Dan Garnet, Kara Sperandio, Gregory P Gauvin, Stephen P Naber, Robert A Weinberg, Michael Rosenblatt.   

Abstract

Currently, an in vivo model of human breast cancer metastasizing from the orthotopic site to bone does not exist, making it difficult to study the many steps of skeletal metastasis. Moreover, models used to identify the mechanisms by which breast cancer metastasizes to bone are limited to intracardiac injection, which seeds the cancer cells directly into the circulation, thus bypassing the early steps in the metastatic process. Such models do not reflect the full process of metastasis occurring in patients. We have developed an animal model of breast cancer metastasis in which the breast cancer cells and the bone target of osteotropic metastasis are both of human origin. The engrafted human bone is functional, based on finding human IgG in the mouse bloodstream, human B cells in the mouse spleen, and normal bone histology. Furthermore, orthotopic injection of a specific human breast cancer cell line, SUM1315 (derived from a metastatic nodule in a patient), later resulted in both bone and lung metastases. In the case of bone, metastasis was to the human implant and not the mouse skeleton, indicating a species-specific osteotropism. This model replicates the events observed in patients with breast cancer skeletal metastases and serves as a useful and relevant model for studying the disease.

Entities:  

Mesh:

Year:  2005        PMID: 16024614     DOI: 10.1158/0008-5472.CAN-04-1408

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  88 in total

1.  Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis.

Authors:  Haijun Zhang; Fanyan Meng; Gang Liu; Bin Zhang; Jun Zhu; Feng Wu; Stephen P Ethier; Fred Miller; Guojun Wu
Journal:  Cancer Res       Date:  2011-02-01       Impact factor: 12.701

2.  Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling.

Authors:  Haijun Zhang; Fanyan Meng; Sherwin Wu; Bas Kreike; Seema Sethi; Wei Chen; Fred R Miller; Guojun Wu
Journal:  Cancer Res       Date:  2011-07-12       Impact factor: 12.701

3.  A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone.

Authors:  Simone Bersini; Jessie S Jeon; Gabriele Dubini; Chiara Arrigoni; Seok Chung; Joseph L Charest; Matteo Moretti; Roger D Kamm
Journal:  Biomaterials       Date:  2013-12-31       Impact factor: 12.479

4.  Ex-vivo analysis of the bone microenvironment in bone metastatic breast cancer.

Authors:  Karen M Bussard; Andrea M Mastro
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-12-02       Impact factor: 2.673

5.  Inhibition of gap junction channel attenuates the migration of breast cancer cells.

Authors:  Kai Zhao; Weili Wang; Caihong Guan; Jie Cai; Ping Wang
Journal:  Mol Biol Rep       Date:  2011-06-15       Impact factor: 2.316

6.  An immunotolerant HER-2/neu transgenic mouse model of metastatic breast cancer.

Authors:  Hong Song; Karineh Shahverdi; David L Huso; Yuchuan Wang; James J Fox; Robert F Hobbs; Barjor Gimi; Kathleen L Gabrielson; Martin G Pomper; Benjamin M Tsui; Zaver Bhujwalla; R Todd Reilly; George Sgouros
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

7.  Polychlorinated biphenyls (PCBs) enhance metastatic properties of breast cancer cells by activating Rho-associated kinase (ROCK).

Authors:  Sijin Liu; Shitao Li; Yuguo Du
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

8.  miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.

Authors:  Li Ma; Jennifer Young; Harsha Prabhala; Elizabeth Pan; Pieter Mestdagh; Daniel Muth; Julie Teruya-Feldstein; Ferenc Reinhardt; Tamer T Onder; Scott Valastyan; Frank Westermann; Frank Speleman; Jo Vandesompele; Robert A Weinberg
Journal:  Nat Cell Biol       Date:  2010-02-21       Impact factor: 28.824

9.  Palladin contributes to invasive motility in human breast cancer cells.

Authors:  S M Goicoechea; B Bednarski; R García-Mata; H Prentice-Dunn; H J Kim; C A Otey
Journal:  Oncogene       Date:  2008-11-03       Impact factor: 9.867

10.  Type I gamma phosphatidylinositol phosphate kinase modulates invasion and proliferation and its expression correlates with poor prognosis in breast cancer.

Authors:  Yue Sun; Dmitry A Turbin; Kun Ling; Narendra Thapa; Samuel Leung; David G Huntsman; Richard A Anderson
Journal:  Breast Cancer Res       Date:  2010-01-14       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.